• Profile
Close

Dose-dependent effects of netarsudil, a Rho-kinase inhibitor, on the distal outflow tract

Graefe's Archive for Clinical and Experimental Ophthalmology May 10, 2020

Chen S, Waxman S, Wang C, et al. - In the present study, the researchers sought to describe the effects of netarsudil, a Rho-kinase inhibitor, on the aqueous humor outflow tract distal to the trabecular meshwork (TM). They assumed that netarsudil increases the outflow facility in eyes with and without circumferential ab interno trabeculectomy (AIT) that removes TM. Sixty-four cultures from the anterior segment of the porcine were randomly allocated to groups with (n = 32) and without circumferential AIT (n = 32). Cultures have been exposed to 0.1, 1, and 10 μM netarsudil (N = 8 eyes per concentration). According to findings, netarsudil at 1 μM decreased IOP both in eyes with TM (− 0.60 ± 0.24 mmHg) and in eyes without TM (− 1.79 ± 0.42 mmHg). Vessels of the distal outflow tract dilated by 72% at this concentration. However, at 0.1 μM netarsudil elevated IOP in eyes with TM (1.59 ± 0.36 mmHg) and in eyes without TM (0.23 ± 0.32 mmHg). The dose-dependent IOP changes caused by netarsudil matched the diameter changes of distal outflow tract vessels in the porcine anterior segment culture. After TM removal, hyper- and hypotensive properties of netarsudil continued.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay